Lichen China Ltd Holds Annual Shareholder Meeting

TL;DR

LICHEN CHINA LTD shareholders met Feb 10, 2025. All good.

AI Summary

Lichen China Limited held its Annual Meeting of Shareholders on February 10, 2025. The meeting took place at 09:00 PM China Time (08:00 AM Eastern Time) at the company's principal office in Xiamen City, Fujian Province, China. The company is a foreign private issuer and files its annual reports under Form 20-F.

Why It Matters

This filing confirms the completion of the annual shareholder meeting, a standard corporate governance event, providing an update on the company's formal proceedings.

Risk Assessment

Risk Level: low — This is a routine filing confirming a shareholder meeting, with no new financial or operational information that would indicate increased risk.

Key Players & Entities

• Lichen China Limited (company) — Registrant
• February 10, 2025 (date) — Date of Annual Meeting
• 001-41493 (company) — Commission File Number

FAQ

Key Financial Figures

• $50,000.00 — zed share capital of the Company from US$50,000.00 divided into (a) 1,000,000,000 series A
• $0.00004 — series A ordinary shares of par value US$0.00004 each and (b) 250,000,000 series B ordin
• $1,000,000.00 — ares of par value US$0.00004 each, to US$1,000,000.00 divided into (a) 20,000,000,000 series

Filing Documents

• ea0230814-6k_lichen.htm (6-K) — 77KB
• ea023081401ex3-1_lichen.htm (EX-3.1) — 201KB
• 0001213900-25-012915.txt ( ) — 279KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month ended February 2025 Commission File No. 001-41493 LICHEN CHINA LIMITED (Translation of registrant’s name into English) 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F Annual Meeting of Shareholders The annual meeting of the shareholders of Lichen China Limited (the “Meeting”) was held on February 10, 2025, at 09:00 PM China Time (February 10, 2025, 08:00 AM Eastern Time), at the principal office of the Company located at 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013. Holders of 1,893,052 Class A Ordinary Shares and 9,000,000 Class B Ordinary Shares of the Company were present in person or by proxy at the Meeting, representing 2.9% and 100% of the voting power of Class A and Class B ordinary shares issued and outstanding as of the record date of December 27, 2024, and therefore constituting a quorum of the Class A and Class B ordinary shares outstanding and entitled to vote at the Meeting as of the record date. Holders of Class B ordinary shares as of the Record Date are entitled to 10 votes for each share held for each of the resolutions. All matters voted on at the Meeting were approved. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows: 1. As an ordinary resolution, “That (a) the increase of the authorized share capital of the Company from US$50,000.00 divided into (a) 1,000,000,000 series A ordinary shares of par value US$0.00004 each and (b) 250,000,000 series B ordinary shares of par value US$0.00004 each, to US$1,000,000.00 divided into (a) 20,000,000,000 series A ordinary shares of par value US$0.00004 each and (b) 5,000,000,000 series B ordinary shares of par value US$0.00004 each, by the creation of additional (a) 19,000,000,000 series A ordinary shares of par value US$0.00004 each and (b) 4,750,000,000 series B ordinary shares of par value US$0.00004 each to rank pari passu in all respects with the existing shares in the capital of the Company be and is hereby approved (the “Share Capital Increase”); and (b) any one director of the Company be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as he or she may consider necessary or desirable to give effect to the Share Capital Increase and the transactions contemplated thereunder and to attend to any necessary registration and/or filing in the Cayman Islands for and on behalf of the Company.” 2. As an ordinary resolution, “That (a) the consolidation of the Company’s issued and unissued series A and series B ordinary shares at a ratio of not less than one (1)-for-twenty (20) and not more than one (1)-for-two hundred (200) (the “Range”), with the exact ratio to be set at a whole number within the Range and the exact effective date to be determined by the board of directors of the Company (the “Board”) in its sole discretion within one year after the date of passing of this resolution (the “Share Consolidation”), provided that no fractional share shall arise from the Share Consolidation, be and is hereby approved; (b) the rounding up of any fractional shares resulting from the Share Consolidation to the nearest whole ordinary share be and is hereby approved and (c) the Board be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as the Board considers necessary or desirable to give effect to the Share Consolidation and the transactions contemplated thereunder, including determining the exact ratio within the Range and the exact effective date of the Share Consolidation and instructing the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation.” 1 3. As a special resolution, “That subject to and conditional upon the passing of Resolution One above in respect of the Share Capital Increase, with immediate effect after the close of this meeting, (a) the amendment of the existing amended and restated memorandum and articles of association of the Company to reflect the Share Capital Increase be and is hereby approved; (b) the amended and restated memorandum and articles of association of the Company (the “Amended and Restated Memorandum and Articles of Association”) be and are hereby a

View Full Filing

View this 6-K filing on SEC EDGAR